Barbara Ann Karmanos Cancer Institute

This study is testing a special tattoo ink designed to fade over time. It aims to see if this 'Magic Ink' is as safe and effective as standard permanent tattoo ink for marking the skin to guide daily radiation therapy in women with breast cancer. Researchers will also check if th…

This study is testing if a new device called TheraBionic P1 can help shrink tumors in people with early-stage breast cancer before they have surgery. The device uses specific radio waves aimed at cancer cells. Researchers will enroll 24 participants to see if adding this device t…

This study is testing whether adding a special radio wave device to standard chemotherapy drugs is safe and can better control advanced pancreatic cancer that has spread. It will involve about 30 adults with this diagnosis. The main goal is to see if this combination can keep the…

This study is testing whether adding a special radiofrequency device to an existing cancer drug helps people with advanced colorectal cancer that has stopped responding to standard treatments. The device emits specific radio waves, and the drug is called fruquintinib. Researchers…

This early-stage study is testing whether adding the common diabetes medication metformin to standard cancer treatments is safe for people with advanced solid tumors. Researchers want to find the highest dose of metformin that can be safely combined with chemotherapy or immunothe…

This study is testing a device called the TheraBionic P1 for people with advanced liver cancer (hepatocellular carcinoma) who have no standard treatment options left. The main goal is to see if using this device can help patients live longer. Researchers will also check how safe …

This early-stage study is testing a new imaging tracer to see if it can help doctors better tell the difference between cancer and normal tissue on a PET/CT scan. Researchers will give the tracer to 24 adults with specific cancers, including brain, breast, and rectal tumors, to s…

This study is testing whether a 12-week high-intensity CrossFit training program can help cancer survivors move better, feel stronger, and improve their quality of life. It will involve 500 participants who have been diagnosed with cancer and are cleared by their doctor to exerci…

This study aims to create and test an online educational program designed with community input to help African American cancer survivors learn about and access genetic counseling and testing. Researchers will work with 85 eligible survivors from Detroit to see if the program incr…